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Abstract
Objective: To identify health-related quality of life (HRQOL) trajectories during 18 mon​ths of predialy​sis care and associated patient characteris​tics and illness percep​tions.  Methods: 396 in​cident predialysis patients parti​ci​pating in the prospective PREPARE-2 study com​pleted every six months the SF-36 (i.e. mental and physical HRQOL) and Revised Illness Percep​tion Ques​t​ion​naire.  HRQOL tra​jec​​​​​​to​ries were examined using latent class growth models, and associa​ted baseline factors were iden​ti​fied using logis​tic regres​sion.  Ana​lyses for illness per​cep​tions were adjust​ed for demo​​​graphic and clini​cal charac​te​ris​tics.  Results: Three phy​sical HRQOL tra​jec​to​ries (low-stable [34.1% of the sample], medium-declining [32.5%], and high-increasing [33.4%]) and two mental HRQOL trajectories (low-stable [38.7%] and high-stable [61.3%]) were iden​ti​fied.  Increased odds for a low-stable phy​si​cal HRQOL trajectory were de​tected in older pa​tients (OR=1.04), patients with car​diovascular dis​ea​se (OR=2.1) and pa​tients who belie​ved to a les​ser extent they can per​sonally control their disease (ORadj=0.88).  Increased odds for both a low-stable physical and mental HRQOL trajectory were detected in patients who be​lieved to a higher extent that their disease is cycli​cal, has ne​ga​​tive consequen​ces, causes nega​ti​ve feel​ings, and in patients who belie​ved to a lesser extent they understand their disease (ORadj ranged between 0.84 and 1.36).  Additionally, patients who attributed more symptoms to their disease had increased odds for a medium-declining (ORadj=1.21) and low-stable phy​si​cal HRQOL trajectory (ORadj= 1.50).  Con​clusions: Older age and cardiovascular disease are mar​kers for unfavorable physi​cal HRQOL trajecto​ries, and stronger negative ill​ness percep​tions are markers for unfa​vo​rable phy​si​cal and mental HRQOL trajectories.  Tar​geting nega​tive illness percep​tions could possibly optimize HRQOL during pre​dialysis care.  
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Health-Related Quality of Life Trajectories during Predialysis Care and Associated Illness Perceptions

Individuals with chronic kidney disease (CKD) suffer from a gradual and irreversible loss of kidney function.  For the majority of patients, this deterioration in kidney function is ac​com​​pa​nied by an increase in symptoms, lifestyle restrictions, and depen​dency on com​plex treat​​​​ment re​gi​mens.  Consequently, this disease imposes a heavy burden on people’s lives, and has a disrup​tive impact on their health, ability to work, emotional well-being, and social par​ti​ci​​​​pation (Tong et al., 2009).
An important indication of how a disease affects the physical, psychological, and social as​pects of patients’ lives, is their rating of health-related quality of life (HRQOL).  In patients with end-stage renal disease (ESRD), HRQOL is severely impaired (Lim, Yu, Kang, Foo, & Griva, 2016).  However, a compromised HRQOL is also evidenced in patients with mo​​derately reduced kidney function and in patients receiving predialysis care (i.e. CKD sta​ges 3-5) (Chin et al., 2008; de Goeij et al., 2014; Kusek et al., 2002), and lower le​vels of HRQOL in these ear​​​lier stages of CKD have been associated with accele​ra​ted pro​gres​​sion to​wards ESRD and mor​ta​li​ty (de Goeij et al., 2014; Tsai et al., 2010).  There​fore, pre​dia​lysis care not only aims to max​​​i​​mi​ze disease con​​trol, but optimizing HRQOL is con​​si​dered an im​por​tant treat​ment goal as well (Sijpkens, Berk​hout-Byrne, & Rabelink, 2008).
Unfortunately, literature regarding HRQOL in patients receiving predialysis care is do​mi​​​​​​nated by cross-sectional studies, and the longitudinal studies that have been conducted found con​tra​​dictory results regarding the course of HRQOL; some studies found that mean levels of both physical and mental HRQOL decrea​s​ed over time (de Goeij et al., 2014; Fuku​ha​ra et al., 2007; Mujais et al., 2009), other stu​dies only found changes in one specific physical or mental HRQOL domain (e.g. in​crea​sed men​​​tal health [Da Silva-Gane et al., 2012], in​crea​s​ed social functioning [Hansen, Chin, Blalock, & Joy, 2009] and decreased physical function (Revicki et al., 1995)]), and there are also studies that found no change in physi​cal or mental HRQOL over time [Di Micco et al., 2009; Goro​de​ts​kaya et al., 2005]).  These con​tra​dictory results might be due to diffe​ren​ces in study design or patient cha​rac​teris​tics, but it is also pos​sible that exami​n​ing mean levels of HRQOL over time mas​ks indi​vidual variation in the cour​se of HRQOL.  In​di​viduals may dif​fer to a lar​ge ex​tent in how their HRQOL devel​ops over time, and the iden​ti​fi​cation of dis​​tinct HRQOL trajec​to​ries and associa​t​ed factors could enable personalized treat​ment ap​proach​​es in predia​lysis care.  How​ever, to the best of our know​ledge, no stu​dies have been con​ducted that identify HRQOL trajectories during pre​dialy​sis care using optimal statisti​cal me​thods such as latent class growth model​ling (Nagin & Odgers, 2010) and identified fac​tors associated with these trajectories. 
Evidently, previous studies do not pro​vide evidence about factors associated with dis​tinct HRQOL trajec​tories during predialysis care, but they do point out potentially important fac​tors, in​​clu​ding age, gender, kidney function, comorbidities, body mass index (BMI), and levels of albumin and hemoglobin (Chin et al., 2008; Gorodetskaya et al., 2005; Hansen et al., 2009; Kusek et al., 2002; Mujais et al., 2009; Porter et al., 2012).  Addi​tio​nally, literature sug​gests that patients’ cogni​​tive ap​prai​sal of ill​ness might play a key role in under​stan​ding HRQOL: accor​​ding to the Com​​mon Sen​se Model of self-regulation (Leventhal, Meyer, & Nerenz, 1980; Leven​thal, Nerenz, & Steele, 1984), illness per​cep​tions ​​affect how patients respond to and cope with a health threat, and subse​quently contribute to health outcomes.  Indeed, studies in patients with CKD show that stronger nega​tive per​​cep​tions of ill​ness are asso​cia​ted with various health outcomes, including depressive sym​ptoms (Chilcot et al., 2013), fas​ter disease progression (Meuleman et al., 2015), mortali​ty (Chilcot, Wellsted, & Far​ring​​ton, 2011; van Dijk et al., 2009) and im​paired HRQOL (Covic, Seica, Gusbeth-Tato​mir, Gavrilovici, & Goldsmith, 2004; Covic, Seica, Mardare, & Gus​beth-Tatomis, 2006; Fowler & Baas, 2006; Griva, Jayasena, Davenport, Harrison, & New​man, 2009; Timmers et al., 2008).  However, until now, the relation​ship between illness percep​tions and HRQOL has only been investi​gated in patients with ESRD and information about the longi​tu​dinal association is scarce.  Examining asso​cia​​tions between illness perceptions and HRQOL trajectories during pre​dialysis care could allow the identification of unhelpful ill​ness perceptions and create opportunities to improve HRQOL in earlier stages of CKD.  
Therefore, the aim of this study was to examine whe​ther distinct physical and mental HRQOL trajectories during predialysis care could be detected, and to examine if these tra​jec​tories are associated with illness perceptions (eight domains: illness identity, timeline acu​te/ chro​nic, timeline cyclical, negative conse​quen​ces, personal control, treatment control, illness coherence, and emotional response), demo​gra​phic (age and gender) and clinical (BMI, comor​bi​dities, kidney function, time since CKD diagno​sis, and levels of albumin and hemo​glo​bin) cha​rac​​te​ristics.  It was hypothesized that distinct HRQOL trajecto​ries would be obser​ved and that the factors would differ across the identified trajec​to​ries.  Due to lacking or inconsis​tent evi​dence, no directional a priori hypotheses were formu​la​ted.

Method
Study Design  
The PREdialysis PAtient REcord-2 (PREPARE-2) study is a pros​pective follow-up study in 25 specialized nephrology outpatient clinics in the Netherlands.  Between July 2004 and June 2011, patients were included at the moment of referral to one of the parti​cipating clinics, where they received regular treatment by a multidisciplinary team (consis​ting of a nephro​​​lo​gist, a nurse practitioner, a dietician, and a social worker) according to the Dutch Federation of Nephro​logy treatment guidelines (Multidisciplinary guide​lines predialysis, 2011; based on Kid​​​ney Disease Outcomes Quality Initiative [K/DOQI, 2002] and Kid​ney Disease Im​pro​ving Global Outcomes [KDIGO, 2012] guide​lines).  Patients were follow​ed until ini​tia​tion of dia​lysis, kidney trans​plan​tation, a recovered kidney function, transferal to non-parti​ci​​pating cen​​​ters, refusal of further participation, death, lost during follow-up, or the end of follow-up (13 May 2015).  Approval by the Medical Ethics Com​mittee or Institutional Review Board of all participating centers was obtained.​[1]​

Patients  
Incident predialysis patients (i.e. within the previous six months referred to a spe​cialized pre​dialysis outpatient clinic) with progressive renal failure and an estimated glo​me​​rular fil​tra​tion rate (eGFR) of less than 30 ml/min/1.73m2 (i.e. CKD stages 4–5), were eligible for inclu​sion, if they were at least 18 years of age.  Patients with a kidney transplant dysfunction were also in​clu​ded, if patients received a donor kidney transplant at least one year ago.  Prior to study inclusion, written informed consent was obtained from all participants.

Data, Definitions, and Measurements
Demographic and clinical data were collected during routine visits at the clinics: at the start of predialysis care, at every subsequent 6-month interval, and at the end of follow-up.  All clinical measurements were collec​ted according to the standard care of each clinic, and labora​to​ry measurement were perio​di​cally ex​tracted from medical records and electronic hospital in​forma​tion systems.  As indi​cator for kidney function, eGFR was calculated by using the abbre​viated Modification of Diet in Renal Disease formula (Levey, Greene, Kusek, & Beck, 2000).  Based on information from medical records, comorbi​dities were clas​sified as follows: dia​betes melli​tus (DM; type 1 or type 2), and cardio​vascular disease (CVD; myo​cardial infar​ction, co​ro​​nary disease, and/or angina pectoris).  							
Patients were also asked to fill out a questionnaire at home, and return the ques​tion​naire as soon as possible.  The ques​tionnaire included the 36-item Short Form Health Survey Ques​tion​naire (SF-36) to assess HRQOL (Ware & Sherbourne, 1992).  The SF-36 items were divi​ded into two summary scores: a physical com​posite score (consisting of four subscales: phy​si​cal func​tion​ing, phy​sical role func​tioning, bodily pain and general health), and a mental com​po​​site score (consisting of four sub​scales: vita​lity, social role functioning, emo​​tional role func​tioning, and mental health).  Scores were trans​​​​formed to a 0–100 score, with higher scores in​dicating better HRQOL.  The SF-36 sho​wed good reliability with Cron​bach alpha values of 0.90 and 0.81 for the physical com​posite score and mental com​posite sco​re respec​ti​vely.  The question​naire also con​tained the Revised Illness Percep​tion Ques​tionnaire to assess illness per​ceptions (Moss-Morris et al., 2002).  Seven domains were derived from 38 items scored on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree): timeline acute/chro​nic, timeline cyclical, nega​tive conse​quences, perso​nal control, treat​​ment control, illness cohe​rence, and emotional response.  The eighth domain ‘illness identity’ was assessed using a sum-score of 14 items in a yes or no format.  Like other studies (e.g. Kim & Evangelista, 2010), illness perception cause was ex​cluded from the analysis due to hete​ro​​ge​ne​ous causes of CKD.  Higher scores on domains reflect that patients attribute more phy​sical sym​​ptoms to their kid​ney disease (i.e. illness identity), and that patients believe to a higher extent their kidney di​s​ea​se is chro​nic and cy​cli​cal in nature, has nega​tive consequences upon their life, causes emo​tio​nal dis​tress, can be effectively con​trol​led by themselves or their treat​ment, and that they un​der​​stand their kidney disease (i.e. illness cohe​rence).  All domains show​ed mode​rate to good relia​bi​lity with Cro​nbach alpha values ranging from 0.63 to 0.90 (see Meuleman et al., 2015).  

Statistical Analysis
To describe patients’ baseline characteristics, descriptive statistics were computed.  Con​ti​nuous variables are presented as mean (standard deviation [SD]) for nor​mally distributed va​ria​bles and as median (interquartile range [IQR]) for skewed variables.  Chi-square tests of as​so​​cia​tion and t-tests were conducted to investigate if patients who were included in and ex​clu​ded from analy​sis differ with regard to baseline characteristics. 
To identify dis​tinct groups of patients that share similar HRQOL trajectories during pre​​​dia​lysis care, latent class growth models (LCGM) were used.  LCGM is a model based clus​ter analy​sis approach in order to determine whether longitudinal changes in an outcome may be best des​cribed by a single or multiple distinct trajectories (i.e. classes; see also Nagin & Od​gers, 2010).  Four time points were included in the analysis (i.e. baseline, and follow-up mea​su​rements at 6, 12 and 18 months) to ensure the availability of sufficient HRQOL mea​su​re​men​ts and fit the models adequately (i.e. LCGM needs at least three time point to fit the mo​dels).  As sug​ge​s​ted by lite​ra​tu​re (Jung & Wickrama, 2008; Nylund, Asparouhov, & Muthén, 2007), we de​ter​mined the opti​mal number of latent tra​jec​tory classes by using a com​​bi​nation of several sta​n​​​​d​ard fit indi​ces: substantial number of participants in each class (at least 5% of the sample), Bayesian Infor​ma​tion Criterion (i.e. lower va​lues indicate a better fit), entropy sum​ma​​ry mea​sures (i.e. entro​py values ran​ge from zero to one, with values clo​ser to one in​di​cating a better quality of the clas​si​fi​cation), and Vuong-Lo-Mendell-Rubin like​lihood test for K-1 vs. K class​es (i.e. a p-value less than 0.05 indicates that the cur​rent model has a bet​ter fit than the model with 1 class less).  Linear and non-linear models were eva​lua​​ted, but in all ca​ses, linear models pro​vided a better fit to the data.  To assess the ade​quacy of the final models, the avera​ge poste​rior proba​bi​​​li​ties were calculated (i.e. a value of at least 0.70 suggests a good proba​bi​lity that partici​pants be​long to the assigned class – there is homogeneity within the class).  Labels were assigned to each identified class ac​cording to the cor​re​spon​​ding class charac​teris​tics: the in​ter​cept (i.e. the base​line score, for in​stan​​ce: low, medium or high), and the magni​tude and direction of the slope (i.e. a stati​sti​cally si​gni​​ficant positive or negative change over time, or the absence of a statistically signifi​cant change over time [i.e. a stable trajectory]) (see results).  A series of univariate 	logistic re​gres​sion analyses were ran to investigate the asso​cia​​tion between the sepa​rate baseline factors (age, gender, eGFR, BMI, DM, CVD, time since CKD diagnosis, serum albumin, hemo​glo​bin, and illness perceptions) and HRQOL class mem​ber​​ship (for details see Jung & Wickrama, 2008).  Analy​ses for illness per​cep​tions were repeated using multino​mial logistic regres​sion analysis to adjust for age, eGFR, DM and CVD.  For both phy​sical and men​tal HRQOL models, the reference cate​gory was the class represen​ting the high​est level of HRQOL (see results), and effects are expres​sed as odds ratios (ORs) with 95% confi​den​ce intervals (CI).  
Descriptive statistics, Chi-square tests of association and t-tests were conducted using SPSS version 24.0.  LCGM and 	logistic regres​sion analyses were ran in Mplus version 7.3, and all models used full-information maximum likelihood estimation to addressing missing data (i.e. using all available data under the assumption that data are missing at random) to ensure max​imum power and avoided bias estimates (Jung & Wickrama, 2008; Muthén & Muthén, 2015).    P-values of <0.05 were consi​dered statisti​cally signi​ficant.

Results
								Of the 502 included patients, 396 patients (78.9%) completed the baseline SF-36 ques​tion​naire (the phy​sical component was completed by 384 patients and the men​tal component by 394 patients) and were in​clu​ded in the analysis.  No significant dif​fe​rences in baseline cha​racteristics (i.e. illness perceptions, demographic and clinical fac​tors; see Table 1) were ob​ser​​ved be​tween patients who were included in and excluded from the analysis, with the exception that exclu​ded patients attributed less physical symptoms to their kidney disease (illness identi​ty; t= -5.0, p= <0.01).  In the inclu​ded sam​ple, the mean age (SD) was 64.4 (14.0) years and the mean (SD) scores for phy​sical and men​​​tal HRQOL were 54.6 (22.2) and 67.9 (20.4) respec​ti​ve​ly. All base​line cha​racteris​tics are shown in Table 1.  
During the first 18 months of predialysis care, 20 patients (5.1%) died, 6 patients (1.5%) experienced a reco​vered kidney function, 21 patients (5.3%) received a kidney transplant, 6 patients (1.5%) were trans​ferred to a non-participating center, 23 patients (5.8%) refused fur​ther participation, and 1 patient (0.3%) was censored for other reasons.  Dialysis was ini​tia​ted in 145 patients (36.6%; 84 patients [57.9%] started on hemodialysis, and 61 patients [42.1%] on peri​to​neal dialysis), and 174 patients (43.9%) still received predialysis care.  The median [IQR] follow-up time in this sample was 16.1 [7.2-32.0] months).  

Distinct Physical HRQOL Trajectory Classes 
A 3-class solution was found to fit the data ade​quately (Table 2).  The three iden​tified class​es of physical HRQOL are summa​rized in Table 3, and Figure 1a depicts the phy​si​cal HRQOL trajec​tories.  The first class termed “low-stable” contained 34.1% of the patients, and was charac​terized by low levels of phy​sical HRQOL that remained stable over time.  The se​cond class (32.5% of the sample), termed “me​dium​-declining”, was defined by a moderate level of physical HRQOL, which significantly worsened with time.  The final class (33.4% of the patients) was a “high-increasing” class, and was charac​te​ri​zed by a high level of phy​sical HRQOL, which signi​ficantly increased over time.

Distinct Mental HRQOL Trajectory Classes  
A two-class solution was deemed adequate for mental HRQOL (Table 2).  The two men​tal HRQOL classes are shown in Table 3, and Figure 1b depicts the mental HRQOL trajecto​ries.  The first class termed “low-stable” contained 38.7% of the patients, and was cha​racteri​zed by low levels of mental HRQOL that remained stable over time.  The second class, termed “high-stable” (61.3% of the sample), was defined by high levels of mental HRQOL that remai​n​ed stable over time.

Factors Associated with Physical HRQOL Class Membership
Of the demo​graphic and clinical factors (age, gender, eGFR, BMI, DM, CVD, time since CKD diag​no​sis, serum albumin and hemoglo​bin) only age and CVD were significantly as​so​​cia​ted with physical HRQOL class membership: compared to the high-increasing physical HRQOL class (class 3), a one-year in​crease in age was associated with a 4% increase in the odds of be​ing in the low-stable physical HRQOL class (class 1; OR=1.04, p<0.01), and the pre​​​sence of CVD was associated with a 2.1 times increase in the odds of being in the low-stable physical HRQOL class (class 1; OR=2.1, p<0.01).  Six out of the eight illness perception domains were also signi​ficantly associated with physical HRQOL class membership while adjusting for age, eGFR and comorbidity (see Tab​le 4 for the crude and ad​jus​ted odd ratio's).  Increased odds for a low-stable phy​sical HRQOL class (class 1) were detected in patients who believed to a lesser extent that they can personally control their kidney disease and that they completely under​stand their con​dition, compared to the high-increasing physical HRQOL class (class 3). Put another way, a single point increase in personal control (higher control) reduced the odds of being in the low-stable class by 12% (ORadj=0.88, p=<0.01) and a single point in​crea​se in co​he​rence (higher coherence) was associated with a 15% reduction in the odds of being in the low-stable class (ORadj=0.85, p=<0.01).  Furthermore, compared to the high-increa​sing physi​cal HRQOL class (class 3), a one-point increase in illness identity, cyclical time​line, nega​tive conse​quen​ces and emotional response increased the odds of being in the low-stable phy​​​​​sical HRQOL class (class 1) by 50%, 36%, 14% and 7% res​pec​ti​ve​ly.  Similar​ly, com​pared to the high-increa​sing physical HRQOL class (class 3), a one-point in​crease in illness iden​tity was associated with a 21% in​crease in the odds of being in the me​dium-decli​ning physical HRQOL class (class 2).  Only trends were found for the odds of being in the me​dium-declining physical HRQOL class (class 2) with regard to the ill​ness percep​tions cycli​cal time​line (OR=1.13, p=0.06) and nega​tive conse​quen​ces (OR=1.14, p=0.05) compared to the high-increa​sing physical HRQOL class (class 3).

Factors Associated with Mental HRQOL Class Membership
None of the de​mo​gra​phic or clinical factors (age, gender, eGFR, BMI, DM, CVD, time since CKD diag​no​sis, levels of se​rum albu​min and hemoglo​bin) were significantly associated with mental HRQOL class mem​ber​ship.  Four out of the eight illness perception domains were sig​​nificantly asso​cia​ted with mental HRQOL class mem​ber​ship while adjusting for age, eGFR and comorbidity (see Table 5 for the crude and ad​jus​ted odd ratio's).  Compared to the high-stable men​tal HRQOL class (class 2), a one-point in​crea​se in cy​clical time​line, negative conse​quen​ces and emotional res​ponse increa​s​ed the odds of be​ing in the low-stable mental HRQOL class (class 1) by 22%, 14% and 7% res​​pec​tively.  Furthermore, increased odds for a low-stable mental HRQOL trajectory (class 1) were detected in patients who believed to a lesser ex​tent that they completely understand their kidney disease compared to the high-stable men​tal HRQOL class (class 2).  Put another way, a single point increase in coherence (higher coheren​ce) was asso​ciated with a 16% reduction in the odds of being in the low-stable class (ORadj= 0.84, p=<0.01).

Discussion
To the best of our knowledge this study is the first to examine distinct trajectories of HRQOL in patients receiving predialysis care using LCGM and to investigate which patient cha​rac​ter​is​tics and illness perceptions at the start of predialysis care are associated with these spe​cific HRQOL trajec​to​ries during predialysis care.  
	This study shows that dis​tinct HRQOL trajectories can be detected during the first 18 months of predialysis care.  Patients indeed dif​fer to a large extent in their evalua​tion of HRQOL over time, and hence, underlines the impor​tance of investigating heterogeneity of HRQOL in this population.  Three physical HRQOL trajectories were observed, all contai​n​ing approximately one-third of our sample: a trajectory in which patients report stable levels of low physical HRQOL, a trajectory in which patients report mo​de​​​​rate levels of physi​cal HRQOL that wor​se​ned over time, and a trajectory in which patients report high levels of phy​sical HRQOL that im​​proved with time.  Additionally, two mental HRQOL trajectories were iden​​​tified: one trajec​t​ory con​tain​ing approximately 60% of our sam​ple in which patients repor​ted stable high le​vels of mental HRQOL, and a se​cond trajectory in which patients repor​ted sta​ble low levels of men​​​​​​tal HRQOL.  These results highlight that a large proportion of our sample has an unfavo​rable (i.e. stable low or declining) HRQOL trajectory during the first 18 mon​ths of predialysis care, which puts them at risk for adverse out​comes such as acce​lera​ted pro​gres​sion to​ward ESRD and morta​lity (de Goeij et al., 2014; Tsai et al., 2010).  Fur​ther​more, the findings that HRQOL remained rather stable in a large proportion of our sam​ple could, to a certain extent, be considered remarkable as the predialysis phase is often con​sidered a dynamic period.  The predialyis phase is charac​teri​zed by an accelerated dis​ease pro​gression, an intensi​fied treat​ment to treat health complica​tions and prepare patients for re​nal replacement therapy (i.e. dialysis or transplantation), an increa​se in overt physical symp​toms and drug-rela​ted side effects, and many patients perceive this phase as a stressful period during which they ex​pe​rien​ce feel​ings as helplessness and hopeless​ness (de Goeij et al., 2014; Ekelund & Ander​sson, 2007; Iles-Smith, 2005; Sijpkens et al., 2008; Tong et al., 2009).  There​​​​​​fore, one might expect that most patients report decreasing le​vels of physical and mental HRQOL during pre​dia​lysis care and this expec​tation is also in line with previous studies that found de​creased mean levels of HRQOL during predialysis care (de Goeij et al., 2014).  How​ever, we did not find decreas​ing levels of physical and mental HRQOL in the majority of our sample and, al​though spe​cula​tive, a possible ex​pla​nation for our findings could be found in the pheno​menon ‘response shift’.  Response shift refers to a chan​ge in individuals’ meaning of HRQOL over time due to changes in their internal standard (e.g. a change in idea what poor health is), values (e.g. re​prio​ritization the importance of cer​tain life domains) and/or recon​cep​tuali​za​tion of the concept HRQOL (Sprangers & Schwartz, 1999).  These cognitive chang​es re​flect patients’ adap​​tation to new situations, and could per​haps ex​plain why patients’ eva​lua​tion of HRQOL did not dec​line but remained rather stable in a large proportion of our sample despite declining health.   Fi​nal​ly, this stability in HRQOL seems particularly applicable to men​tal HRQOL: men​​​tal HRQOL remained rather stable in all patients while physical HRQOL remain​ed stable in only one-third of our sample.  A possible explanation for this dif​fe​rence could be that pre​dia​​lysis care is relatively more focused on the treatment of physical aspects compared to the men​tal aspects of the disease (Multidisciplinary guidelines predialysis, 2011).     
Ante​ce​​dent factors asso​cia​ted with diffe​r​ent HRQOL tra​jec​tories were also examined in this study. The results showed that none of the demographic or clinical fac​tors were asso​cia​​ted with mental HRQOL class membership, how​​ever, age and CVD were associated with physical HRQOL class member​ship: increased odds for a low-stable phy​sical HRQOL tra​jec​to​​ry were detected in older patients and patients diagnosis with CVD.  In addition, six out of the eight illness percep​tions were associated with HRQOL class mem​​​​​bership; increased odds for both a low-stable phy​si​cal and mental HRQOL tra​jec​tory were detected in patients who be​lieved to a higher ex​tent that their kidney disease has an un​pre​dic​​ta​ble cyclical nature, has ne​gative conse​quen​ces upon their lives, causes emotional dis​tress, and in patients who belie​ved to a lesser extent that they fully under​stand their kidney disease.  Additionally, increased odds for a low-stable phy​si​cal HRQOL were detected in patients who believed to a lesser ex​tent that they can per​son​ally control their disease, and in​creased odds of a low-stable and me​dium-decli​ning physical HRQOL trajectory was detected in patients who attributed more phy​sical symp​toms to their kidney disease.  These findings are in line with and builds on pre​vious stu​​dies that found lower mean levels of HRQOL in patients with CKD associated with an ol​der age (Chin et al., 2008), CVD (Chin et al., 2008; Mujais et al., 2009) and stronger ne​ga​tive per​ceptions of illness, inclu​ding ill​ness iden​ti​ty, cyclical time​line, negative con​se​quen​ces, per​so​nal con​trol, ill​ness coherence and emo​tio​nal response (Covic et al., 2004, 2006; Fowler & Baas, 2006; Griva et al., 2009; Timmers et al., 2008).  
An explanation for the relationship between illness perceptions and HRQOL found in this study can be derived from the Common Sense Model of self-regulation (Leventhal et al., 1980, 1984).  This theo​re​tical frame​work suggests that patients’ percep​tions of illness sha​pe their cog​ni​tive and beha​​​vioral adjust​ment to managing their ill​ness (i.e. co​ping process and illness related behaviors) and consequently contribute to health out​co​mes.  For our re​sults, this could mean that patients with stron​ger nega​​tive illness perceptions deal with their kid​ney disease in more mal​a​dap​tive ways (e.g. denial, non-adhe​rence to treatment gui​​​delines, and not seeking sup​port), and con​se​​quently result in im​paired or dete​rio​rating HRQOL.  Until now, the evidence for this explanation in patients with CKD is contradic​t​ory and limited to only a few cross-sectional studies; Knowles, et at. (2014) found (mal)a​daptive co​ping to mediate the rela​tionship between ill​ness percep​tions and psy​cho​l​o​gi​cal well-being, whereas Kim & Evan​gelista (2010) did not find adhe​rence to treatment guide​lines to mediate the rela​tion​ship be​tween illness per​cep​tions and clinical outco​mes.  More​over, a recent meta-analysis also con​clu​ded that evidence for coping as a po​ten​tial media​tor in the relationship between illness perceptions and psychological health in people with other conditions was inconsistent (Dempster, Howell, & McCorry, 2015).  There​​​fore, addi​tional re​search is needed to further ex​plore this potentially media​ting role of co​ping and health behaviors in the relation​ship between illness percep​tions and HRQOL tra​jec​​tories during predialysis care.  
Taken together, the results of this study suggest that in many patients physical and men​​tal HRQOL re​main​ed com​promi​sed or became impaired during the first 18 months of predia​lysis care.  Hence, implementing additional strategies at the start of predialysis care to support patients at risk for impaired HRQOL is required.  Our results also suggest that ill​ness percep​tions are, compared to the demographic and clinical factors, most closely rela​ted to HRQOL trajectories.  This latter finding is especially important because literature shows that unhelpful illness per​ceptions can be changed by means of psy​cho​educational inter​ven​tions, and conse​quently im​prove outcomes (Karamanidou, Weinman, & Horne, 2008; Petrie, Cameron, Ellis, Buick, & Weinman, 2002).  Based on our results, key aspects of such interventions to opti​mize HRQOL would be to target un​helpful beliefs about ill​ness iden​ti​ty, cyclical time​line, con​se​quences, per​sonal con​trol, illness coherence and emo​tio​nal response.  Examples of sup​port strategies that could be imple​mented to target these unhelpful illness perceptions are: edu​​cation (e.g. enhan​cing know​ledge about kidney disease and how they can per​sonally in​fluence disease pro​gression by adopting a heal​thy lifestyle), challenge mis​concep​tions (e.g. about the unpredic​ta​ble cyclical nature of CKD and related symptoms), and deve​lop action plans (e.g. how to deal with emotio​nal dis​tress and the negative con​se​quen​ces that the disease has upon their lives, for instance by means of reat​tri​​bution or increasing social support) (Kara​manidou et al., 2008; Petrie et al., 2002). How​ever, pilot studies are needed to evaluate if illness perception-based interven​tions would indeed improve HRQOL trajectories in patients receiving predialysis care. 
The main strength of this study is the longitudinal instead of cross-sectional de​sign that provi​ded the opportunity to investigate changes in HRQOL over time.  The PREPARE-2 data​set also offers informa​tion on a broad range of factors (i.e. HRQOL, illness per​cep​tions, and variety of demographic and clinical factors) in a large sample of patients.  A disadvan​tage of this obser​va​tional design is that causal interpretation is still limited.  Furthermore, a selection bias could have been introduced as not all eligible patients starting predialysis care have been included in this study (i.e. only patients who were asked and willing to participate).  Poten​tial​ly, un​id​en​​​tified confounding could also have led to biased results: i.e. a de​crea​sed health status at the start of pre​dialysis care could have caused both stronger negative ill​ness perceptions and im​pai​red HRQOL trajectories.  However, we believe that we adequately ad​jus​ted for disease se​​verity (i.e. age, kid​ney fun​c​tion, and comorbidities), and the re​sults from the crude and ad​justed analyses were very similar.  Besides this, there is missing data as some patients did not (fully) complete the question​naire (i.e. the question​naire was not return​ed or insufficiently fil​led out), did not visit the predia​lysis out​patient cli​nic every six months or reached a study end​point.  How​​ever, it is unlikely that our missing data led to biased results, sin​ce little differences in baseline characteris​tics were ob​served be​tween patients who were inclu​d​​​ed in and exclu​ded from the ana​ly​ses.  More​over, to en​sure maximum power and avoided bias estimates, missing data was treated using full-informa​tion max​i​mum likeli​hood estima​tion, and there was no evi​dence that missing data was not ran​dom in nature.  Final​ly, ad​di​tional research is needed to con​​firm our results, to assess how HRQOL tra​jec​tories de​velop after 18 months of predialysis care, and to investigate if changes in illness per​cep​tions would also lead to changes in HRQOL tra​jec​tories in patients re​ceiving pre​dialysis care.  
Despite these limitations and the need for future research, this study identified va​r​ious im​por​tant markers for unfavorable HRQOL tra​jectories: an old​er age and the pres​en​ce of CVD were associated with unfavorable physical HRQOL trajec​to​ries, and strong​er ne​gative percep​tions of illness at the start of pre​dialysis care were asso​cia​ted with unfa​vora​ble phy​sical and mental HRQOL trajec​to​ries.  Persona​lized treatment approaches to optimize HRQOL during predialysis care are desired and should take into account illness perceptions. 
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Age, years, mean ± SD	64.4 (14.0)
Sex, female, N (%)	135 (34.1)
Clinical	
Time since CKD diagnosis, median (IQR) years □	12.0 (9.0-20.0)
Diabetes mellitus, N (%)	101 (25.5)
Cardiovascular disease, N (%)	161 (40.7)
Body mass index (kg/m2), mean ± SD □□	26.6 ± 5.0
eGFR (ml/min/1.73m2), mean ± SD □□□	16.8 ± 6.1
Serum albumin (g/l), mean  ± SD †	40.9 ± 4.6
Hemoglobin (g/dl), mean ± SD ‡	12.3 ± 1.5
Psychosocial	
Physical HRQOL (range 0-100), mean ± SD *, a	54.6 ± 22.2
Mental HRQOL (range 0-100), mean ± SD **, a	67.9 ± 20.4
Illness identity (range 0-14), mean ± SD b	3.1 ± 2.5
Timeline acute/chronic (range 6-30), mean ± SD b	24.9 ± 4.2
Cyclical timeline (range 4-20), mean ± SD a	11.3 ± 3.4
Negative consequences (range 6-30), mean ± SD b	20.6 ± 4.1
Personal control (range 6-30), mean ± SD b	18.0 ± 4.1
Treatment control (range 5-25), mean ± SD b	15.2 ± 3.0
Illness coherence (range 5-25), mean ± SD b	17.4 ± 4.1
Emotional response (range 6-30), mean ± SD b	16.5 ± 5.3

Note.  Continuous variables are presented as mean ± SD for normally distributed variables and as median (IQR) for skewed variables.  
Abbreviations: HRQOL, Health-related quality of life; eGFR, estimated glomerular filtration rate; SD, standard deviation; IQR, interquartile range.
Complete data available with the exception of the following variables with data available for: □381 (96.2%), □□388 (98.0%), □□□351 (88.6%), †325 (82.1%), ‡349 (88.1%), *384 (97.0%), **394 (99.5%).
a Mean scores of the general Dutch population for physical and mental HRQOL are 76.3 and 
  77.9 respectively (these mean physical and mental HRQOL composite scores were calcu​la-​
  ted based on unstandardized mean scores of the SF-36 subscales described by Aaron​son et   al., 1998
  al., 1998.
b Higher scores on illness perception domains reflect that patients attribute more phy​sical 
  symp​toms to their kidney disease (i.e. illness identity), and that patients believe to a higher 
  extent their kidney disease is chro​nic and cy​clical in nature, has negative consequences 
  upon their life, causes emotional dis​tress, can be effec​tively con​trol​led by themselves or 




Latent class growth model fit specification for physical and mental HRQOL classes
Number of classes:	1	2	3 a	4
Physical HRQOL				
Number of free Parameters	6	9	12	15
Log likelihood 	-4162.26	-3978.54	-3931.15	-3920.26
Bayesian Information Criterion	 8360.54	 8011.10	 7934.32	 7930.55
Entropy	-	  0.73	  0.67	  0.68
Vuong-Lo-Mendell-Rubin likelihood       test for K-1 vs. K classes, p-value	-	<0.01	<0.01	  0.09
Number of classes:	1	2 b	3	4
Mental HRQOL				
Number of free Parameters	6	9	12	15
Log likelihood	-4111.98	-3961.41	-3929.53	-3913.31
Bayesian Information Criterion	 8235.96	 7976.94	 7931.21	 7916.79
Entropy	-	  0.76	  0.67	  0.63
Vuong-Lo-Mendell-Rubin likelihood        test for K-1 vs. K classes, p-value	-	<0.01	  0.36	  0.03

Abbreviation: HRQOL, Health-related quality of life
a A three-class solution had the best model fit as determined by the combination of the fit in-​
  dices, and the average posterior probabilities for each trajectory class were higher than 0.70 
  (0.85, 0.77, and 0.90 respectively).
b A two-class solution had the best model fit as determined by the combination of the fit in​-
  dices, and the average posterior probabilities for each trajectory class were higher than 0.70 
  (0.91 and 0.94, respectively).    
 Table 3
Class solutions for physical HRQOL (n=384) and mental HRQOL (n=394) a




Class 3	High-increasing	75.28**	 1.84*	128 (33.4)
Mental HRQOL 				
Class 1 	Low-stable	48.86**	-1.41	152 (38.7)
Class 2	High-stable	80.13**	-0.61	242 (61.3)

Abbreviation: HRQOL, Health-related quality of life.
a The median (IQR) number of HRQOL measurements was 2 (1–3) during the first 18 months 
  of predialysis care. Physical and mental HRQOL scores available at follow-up were: 260 
  (67.7%) and 261 (66.2%) at 6 months, 169 (44.0%) and 168 (42.6%) at 12 months, and 102 
   (26.6%) and 102 (25.9%) at 18 months respecti​ve​ly.  
b Change in HRQOL scores per 6 months during the first 18 months of predialysis care. 
* p < 0.05, **p < 0.01.






Factors associated with physical HRQOL class membership (n=384)
	Class 1 aLow-stable physical HRQOL	Class 2 aMedium-declining  physical HRQOL
	UnadjustedOR (95% CI)	Adjusted bOR (95% CI)	UnadjustedOR (95% CI)	Adjusted bOR (95% CI)
Illness identity	1.31 (1.18–1.46)**	1.50 (1.26–1.79)**	1.18 (1.03–1.34)*	1.21 (1.02–1.44)*
Timeline acute/chronic	0.98 (0.90–1.06)	0.98 (0.90–1.06)	1.03 (0.93–1.15)	1.05 (0.93–1.18)
Cyclical timeline	1.20 (1.05–1.35)*	1.36 (1.14–1.58)*	1.16 (1.06–1.27)**	1.13 (1.00–1.26)
Negative consequences	1.08 (1.01–1.16)*	1.14 (1.02–1.25)*	1.18 (1.08–1.23)*	1.14 (1.00–1.28)
Personal control	0.90 (0.82–0.98)*	0.88 (0.78–0.97)**	0.97 (0.89–1.06)	0.99 (0.90–1.08)
Treatment control	0.94 (0.77–1.12)	1.11 (0.97–1.24)	0.99 (0.88–1.09)	1.09 (0.96–1.23)
Illness coherence	0.83 (0.65–1.06)	0.85 (0.74–0.95)**	0.95 (0.81–1.12)	0.95 (0.86–1.03)
Emotional response	1.02 (0.97–1.08)	1.07 (1.00–1.15)*	1.05 (0.97–1.13)	1.05 (0.96–1.13)

Abbreviations: OR, Odds ratio; CI, confidence interval.
Note: Higher scores on domains reflect that patients attribute more phy​sical symptoms to their kidney disease (i.e. illness identity), and that patients believe to a higher extent their kidney disease is chro​nic and cyclical in nature, has negative consequences upon their life, causes emotional dis​tress, can be effectively con​trol​led by themselves or their treatment, and that they understand their kidney disease (i.e. illness coherence).
a Reference class: high-increasing physical HRQOL (class 3).
b Adjusted for age, kidney function, and comorbidities.





Factors associated of mental HRQOL class membership (n=394)
	Class 1 aLow-stable mental HRQOL
	UnadjustedOR (95% CI)	Adjusted bOR (95% CI)	
Illness identity	1.24 (1.08–1.42)**	1.06 (0.80–1.26)	
Timeline acute/chronic	0.98 (0.91–1.04)	0.99 (0.92–1.06)	
Cyclical timeline	1.18 (1.09–1.28)**	1.22 (1.11–1.32)**	
Negative consequences	1.10 (1.04–1.18)**	1.14 (1.05–1.23)**	
Personal control	0.94 (0.88–1.00)	0.99 (0.92–1.06)	
Treatment control	1.00 (0.93–1.09)	1.02 (0.93–1.10)	
Illness coherence	0.86 (0.79–0.93)**	0.84 (0.76–0.93)**	
Emotional response	1.06 (0.99–1.12)	1.07 (0.87–0.99) *	

Abbreviations: OR, Odds ratio; CI, confidence interval.
Note:  Higher scores on domains reflect that patients attribute more phy​sical symptoms to their kidney disease (i.e. illness identity), and that patients believe to a higher extent their kidney disease is chro​nic and cyclical in nature, has negative consequences upon their life, causes emotional dis​tress, can be effectively con​trol​led by themselves or their treatment, and that they understand their kidney disease (i.e. illness coherence).
a Reference class: high-stable mental HRQOL (class 2).
b Adjusted for age, kidney function, and comorbidities.












^1	  Participating centers: Academic Medical Center (Amsterdam), Sint Lucas-Andreas Hospital (Amsterdam), VU Medical Center (Amsterdam), Gelre Hospitals (Apeldoorn), Amphia Hospital (Breda), Reinier de Graaf (Delft), Jeroen Bosch Hospital (Den Bosch), Medical Center Haaglanden (The Hague), Hospital Gelderse Vallei (Ede), Catharina Hospital (Eindhoven), Scheper Hospital (Emmen), Dialysis Clinic North (Beilen), Admiraal de Ruyter Hospital (Goes), Groene Hart Hospital (Gouda), University Medical Center Groningen (Groningen), Kennemer Gasthuis (Haarlem), Medical Center Leeuwarden (Leeuwarden), Leiden University Medical Center (Leiden), Rijnland Hospital (Leiderdorp), Laurentius Hospital (Roermond), Franciscus Hospital (Roosendaal), Franciscus Gasthuis (Rotterdam), Máxima Medical Center (Veldhoven), Zaans Medical Center (Zaandam), Isala Clinics (Zwolle).
